In this global study of young BRCA carriers with breast cancer, distinct patient, tumor, and treatment characteristics and a different pattern and risk of survival events over time were observed between patients carrying germline BRCA1 and BRCA2 PVs. This evidence concerns the gene BRCA1 and breast carcinoma.